aluates Reports

$ 0.0

Global β-Nicotinamide Mononucleotide (NMN) Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-16K9169

Global β Nicotinamide Mononucleotide NMN Market Insights and Forecast to 2028

BUY CHAPTERS

Global β-Nicotinamide Mononucleotide (NMN) Market Research Report 2025

Code: QYRE-Auto-16K9169

Report

March 2025

Pages:86

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

GeneHarbor

Herbalmax

Genex Formulas

Maac10 Formulas

EffePharm

Bontac

CELFULL

Kingdomway

Mirailab Bioscience

ABA Chemical

β-Nicotinamide Mononucleotide (NMN) Market Size

The global market for β-Nicotinamide Mononucleotide (NMN) was valued at US$ 418 million in the year 2024 and is projected to reach a revised size of US$ 992 million by 2031, growing at a CAGR of 13.4% during the forecast period.

β-Nicotinamide Mononucleotide (NMN) Market

Nicotinamide mononucleotide (NMN) is an intermediate of NAD+ biosynthesis produced from nicotinamide through nicotinamide phosphoribosyltransferase (NAMPT) and also referred to as NMN or nicotinamide ribotide. In recent studies of NMN applications to prevention and diagnosis of age-dependent diseases such as diabetes, neurodegenerative disorder, cardiac disease etc., it has become one of hottest biomarkers on discussion for anti-aging, lately.

NMN is a precursor of nicotinamide adenine dinucleotide (NAD+), which plays a vital role in cell metabolism and energy production. As we age, the level of NAD+ in the human body gradually decreases, resulting in weakened cell metabolism, which in turn triggers a series of aging-related diseases. Therefore, increasing the level of NAD+ in the body by supplementing NMN has become a new way to fight aging and maintain good health.

With the general improvement of global health awareness and continuous breakthroughs in scientific research and technology, the growth momentum of the NMN market will continue to increase. In the future, the NMN market will achieve a deeper cross-border integration with other health industries such as biotechnology, precision medicine, and nutritional supplements, giving rise to a series of innovative products and service models to meet consumers' more personalized and precise health needs.

At present, nicotinamide mononucleotide (NMN) is still in the development stage. There are not many manufacturers in the global market, and consumers have weak awareness of its use, especially in developing countries. The demand is lower than that in developed countries around the world, but the demand in developing countries is growing rapidly. Leading giants have proposed expansion plans and increased production bases.

Nicotinamide mononucleotide (NMN) core manufacturers include GeneHarbor, Mirailab Bioscience, Maac10 Formulas, Herbalmax and Genex Formula. China is the largest production area, accounting for about 84% of the global market share, followed by North America and Japan. The downstream applications of nicotinamide mononucleotide include health products, cosmetics, etc. Globally, health products are the largest application market, and raw materials for health products account for 99% of the total sales of nicotinamide mononucleotide in 2023.

Report Scope

This report aims to provide a comprehensive presentation of the global market for β-Nicotinamide Mononucleotide (NMN), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding β-Nicotinamide Mononucleotide (NMN).

The β-Nicotinamide Mononucleotide (NMN) market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global β-Nicotinamide Mononucleotide (NMN) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the β-Nicotinamide Mononucleotide (NMN) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of β-Nicotinamide Mononucleotide (NMN) Market Report

Report Metric	Details
Report Name	β-Nicotinamide Mononucleotide (NMN) Market
Accounted market size in year	US$ 418 million
Forecasted market size in 2031	US$ 992 million
CAGR	13.4%
Base Year	year
Forecasted years	2025 - 2031
by Type	Content ≥98% Content ＜98%
by Application	Health Care Products Cosmetics Others
Production by Region	North America China Japan
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	GeneHarbor, Herbalmax, Genex Formulas, Mirailab Bioscience, Maac10 Formulas, EffePharm, Bontac, CELFULL, Kingdomway, ABA Chemical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of β-Nicotinamide Mononucleotide (NMN) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of β-Nicotinamide Mononucleotide (NMN) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of β-Nicotinamide Mononucleotide (NMN) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

FAQ for this report

How fast is β-Nicotinamide Mononucleotide (NMN) Market growing?

Ans: The β-Nicotinamide Mononucleotide (NMN) Market witnessing a CAGR of 13.4% during the forecast period 2025-2031.

What is the β-Nicotinamide Mononucleotide (NMN) Market size in 2031?

Ans: The β-Nicotinamide Mononucleotide (NMN) Market size in 2031 will be US$ 992 million.

What is the β-Nicotinamide Mononucleotide (NMN) Market production share by region?

Ans: China is the largest production area, accounting for about 84% of the global market share, followed by North America and Japan.

Who are the main players in the β-Nicotinamide Mononucleotide (NMN) Market report?

Ans: The main players in the β-Nicotinamide Mononucleotide (NMN) Market are GeneHarbor, Herbalmax, Genex Formulas, Mirailab Bioscience, Maac10 Formulas, EffePharm, Bontac, CELFULL, Kingdomway, ABA Chemical

What are the Application segmentation covered in the β-Nicotinamide Mononucleotide (NMN) Market report?

Ans: The Applications covered in the β-Nicotinamide Mononucleotide (NMN) Market report are Health Care Products, Cosmetics, Others

What are the Type segmentation covered in the β-Nicotinamide Mononucleotide (NMN) Market report?

Ans: The Types covered in the β-Nicotinamide Mononucleotide (NMN) Market report are Content ≥98%, Content ＜98%

1 β-Nicotinamide Mononucleotide (NMN) Market Overview

1.1 Product Definition

1.2 β-Nicotinamide Mononucleotide (NMN) by Type

1.2.1 Global β-Nicotinamide Mononucleotide (NMN) Market Value Growth Rate Analysis by Type: 2024 VS 2031

1.2.2 Content ≥98%

1.2.3 Content ＜98%

1.3 β-Nicotinamide Mononucleotide (NMN) by Application

1.3.1 Global β-Nicotinamide Mononucleotide (NMN) Market Value Growth Rate Analysis by Application: 2024 VS 2031

1.3.2 Health Care Products

1.3.3 Cosmetics

1.3.4 Others

1.4 Global Market Growth Prospects

1.4.1 Global β-Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts (2020-2031)

1.4.2 Global β-Nicotinamide Mononucleotide (NMN) Production Capacity Estimates and Forecasts (2020-2031)

1.4.3 Global β-Nicotinamide Mononucleotide (NMN) Production Estimates and Forecasts (2020-2031)

1.4.4 Global β-Nicotinamide Mononucleotide (NMN) Market Average Price Estimates and Forecasts (2020-2031)

1.5 Assumptions and Limitations

2 Market Competition by Manufacturers

2.1 Global β-Nicotinamide Mononucleotide (NMN) Production Market Share by Manufacturers (2020-2025)

2.2 Global β-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Manufacturers (2020-2025)

2.3 Global Key Players of β-Nicotinamide Mononucleotide (NMN), Industry Ranking, 2023 VS 2024

2.4 Global β-Nicotinamide Mononucleotide (NMN) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.5 Global β-Nicotinamide Mononucleotide (NMN) Average Price by Manufacturers (2020-2025)

2.6 Global Key Manufacturers of β-Nicotinamide Mononucleotide (NMN), Manufacturing Base Distribution and Headquarters

2.7 Global Key Manufacturers of β-Nicotinamide Mononucleotide (NMN), Product Offered and Application

2.8 Global Key Manufacturers of β-Nicotinamide Mononucleotide (NMN), Date of Enter into This Industry

2.9 β-Nicotinamide Mononucleotide (NMN) Market Competitive Situation and Trends

2.9.1 β-Nicotinamide Mononucleotide (NMN) Market Concentration Rate

2.9.2 Global 5 and 10 Largest β-Nicotinamide Mononucleotide (NMN) Players Market Share by Revenue

2.10 Mergers & Acquisitions, Expansion

3 β-Nicotinamide Mononucleotide (NMN) Production by Region

3.1 Global β-Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

3.2 Global β-Nicotinamide Mononucleotide (NMN) Production Value by Region (2020-2031)

3.2.1 Global β-Nicotinamide Mononucleotide (NMN) Production Value by Region (2020-2025)

3.2.2 Global Forecasted Production Value of β-Nicotinamide Mononucleotide (NMN) by Region (2026-2031)

3.3 Global β-Nicotinamide Mononucleotide (NMN) Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

3.4 Global β-Nicotinamide Mononucleotide (NMN) Production Volume by Region (2020-2031)

3.4.1 Global β-Nicotinamide Mononucleotide (NMN) Production by Region (2020-2025)

3.4.2 Global Forecasted Production of β-Nicotinamide Mononucleotide (NMN) by Region (2026-2031)

3.5 Global β-Nicotinamide Mononucleotide (NMN) Market Price Analysis by Region (2020-2025)

3.6 Global β-Nicotinamide Mononucleotide (NMN) Production and Value, Year-over-Year Growth

3.6.1 North America β-Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts (2020-2031)

3.6.2 China β-Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts (2020-2031)

3.6.3 Japan β-Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts (2020-2031)

4 β-Nicotinamide Mononucleotide (NMN) Consumption by Region

4.1 Global β-Nicotinamide Mononucleotide (NMN) Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

4.2 Global β-Nicotinamide Mononucleotide (NMN) Consumption by Region (2020-2031)

4.2.1 Global β-Nicotinamide Mononucleotide (NMN) Consumption by Region (2020-2025)

4.2.2 Global β-Nicotinamide Mononucleotide (NMN) Forecasted Consumption by Region (2026-2031)

4.3 North America

4.3.1 North America β-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.3.2 North America β-Nicotinamide Mononucleotide (NMN) Consumption by Country (2020-2031)

4.3.3 U.S.

4.3.4 Canada

4.4 Europe

4.4.1 Europe β-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.4.2 Europe β-Nicotinamide Mononucleotide (NMN) Consumption by Country (2020-2031)

4.4.3 Germany

4.4.4 France

4.4.5 U.K.

4.4.6 Italy

4.4.7 Russia

4.5 Asia Pacific

4.5.1 Asia Pacific β-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Region: 2020 VS 2024 VS 2031

4.5.2 Asia Pacific β-Nicotinamide Mononucleotide (NMN) Consumption by Region (2020-2031)

4.5.3 China

4.5.4 Japan

4.5.5 South Korea

4.5.6 China Taiwan

4.5.7 Southeast Asia

4.5.8 India

4.6 Latin America, Middle East & Africa

4.6.1 Latin America, Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.6.2 Latin America, Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Consumption by Country (2020-2031)

4.6.3 Mexico

4.6.4 Brazil

4.6.5 Turkey

4.6.6 GCC Countries

5 Segment by Type

5.1 Global β-Nicotinamide Mononucleotide (NMN) Production by Type (2020-2031)

5.1.1 Global β-Nicotinamide Mononucleotide (NMN) Production by Type (2020-2025)

5.1.2 Global β-Nicotinamide Mononucleotide (NMN) Production by Type (2026-2031)

5.1.3 Global β-Nicotinamide Mononucleotide (NMN) Production Market Share by Type (2020-2031)

5.2 Global β-Nicotinamide Mononucleotide (NMN) Production Value by Type (2020-2031)

5.2.1 Global β-Nicotinamide Mononucleotide (NMN) Production Value by Type (2020-2025)

5.2.2 Global β-Nicotinamide Mononucleotide (NMN) Production Value by Type (2026-2031)

5.2.3 Global β-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Type (2020-2031)

5.3 Global β-Nicotinamide Mononucleotide (NMN) Price by Type (2020-2031)

6 Segment by Application

6.1 Global β-Nicotinamide Mononucleotide (NMN) Production by Application (2020-2031)

6.1.1 Global β-Nicotinamide Mononucleotide (NMN) Production by Application (2020-2025)

6.1.2 Global β-Nicotinamide Mononucleotide (NMN) Production by Application (2026-2031)

6.1.3 Global β-Nicotinamide Mononucleotide (NMN) Production Market Share by Application (2020-2031)

6.2 Global β-Nicotinamide Mononucleotide (NMN) Production Value by Application (2020-2031)

6.2.1 Global β-Nicotinamide Mononucleotide (NMN) Production Value by Application (2020-2025)

6.2.2 Global β-Nicotinamide Mononucleotide (NMN) Production Value by Application (2026-2031)

6.2.3 Global β-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Application (2020-2031)

6.3 Global β-Nicotinamide Mononucleotide (NMN) Price by Application (2020-2031)

7 Key Companies Profiled

7.1 GeneHarbor

7.1.1 GeneHarbor β-Nicotinamide Mononucleotide (NMN) Company Information

7.1.2 GeneHarbor β-Nicotinamide Mononucleotide (NMN) Product Portfolio

7.1.3 GeneHarbor β-Nicotinamide Mononucleotide (NMN) Production, Value, Price and Gross Margin (2020-2025)

7.1.4 GeneHarbor Main Business and Markets Served

7.1.5 GeneHarbor Recent Developments/Updates

7.2 Herbalmax

7.2.1 Herbalmax β-Nicotinamide Mononucleotide (NMN) Company Information

7.2.2 Herbalmax β-Nicotinamide Mononucleotide (NMN) Product Portfolio

7.2.3 Herbalmax β-Nicotinamide Mononucleotide (NMN) Production, Value, Price and Gross Margin (2020-2025)

7.2.4 Herbalmax Main Business and Markets Served

7.2.5 Herbalmax Recent Developments/Updates

7.3 Genex Formulas

7.3.1 Genex Formulas β-Nicotinamide Mononucleotide (NMN) Company Information

7.3.2 Genex Formulas β-Nicotinamide Mononucleotide (NMN) Product Portfolio

7.3.3 Genex Formulas β-Nicotinamide Mononucleotide (NMN) Production, Value, Price and Gross Margin (2020-2025)

7.3.4 Genex Formulas Main Business and Markets Served

7.3.5 Genex Formulas Recent Developments/Updates

7.4 Mirailab Bioscience

7.4.1 Mirailab Bioscience β-Nicotinamide Mononucleotide (NMN) Company Information

7.4.2 Mirailab Bioscience β-Nicotinamide Mononucleotide (NMN) Product Portfolio

7.4.3 Mirailab Bioscience β-Nicotinamide Mononucleotide (NMN) Production, Value, Price and Gross Margin (2020-2025)

7.4.4 Mirailab Bioscience Main Business and Markets Served

7.4.5 Mirailab Bioscience Recent Developments/Updates

7.5 Maac10 Formulas

7.5.1 Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Company Information

7.5.2 Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Product Portfolio

7.5.3 Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Production, Value, Price and Gross Margin (2020-2025)

7.5.4 Maac10 Formulas Main Business and Markets Served

7.5.5 Maac10 Formulas Recent Developments/Updates

7.6 EffePharm

7.6.1 EffePharm β-Nicotinamide Mononucleotide (NMN) Company Information

7.6.2 EffePharm β-Nicotinamide Mononucleotide (NMN) Product Portfolio

7.6.3 EffePharm β-Nicotinamide Mononucleotide (NMN) Production, Value, Price and Gross Margin (2020-2025)

7.6.4 EffePharm Main Business and Markets Served

7.6.5 EffePharm Recent Developments/Updates

7.7 Bontac

7.7.1 Bontac β-Nicotinamide Mononucleotide (NMN) Company Information

7.7.2 Bontac β-Nicotinamide Mononucleotide (NMN) Product Portfolio

7.7.3 Bontac β-Nicotinamide Mononucleotide (NMN) Production, Value, Price and Gross Margin (2020-2025)

7.7.4 Bontac Main Business and Markets Served

7.7.5 Bontac Recent Developments/Updates

7.8 CELFULL

7.8.1 CELFULL β-Nicotinamide Mononucleotide (NMN) Company Information

7.8.2 CELFULL β-Nicotinamide Mononucleotide (NMN) Product Portfolio

7.8.3 CELFULL β-Nicotinamide Mononucleotide (NMN) Production, Value, Price and Gross Margin (2020-2025)

7.8.4 CELFULL Main Business and Markets Served

7.8.5 CELFULL Recent Developments/Updates

7.9 Kingdomway

7.9.1 Kingdomway β-Nicotinamide Mononucleotide (NMN) Company Information

7.9.2 Kingdomway β-Nicotinamide Mononucleotide (NMN) Product Portfolio

7.9.3 Kingdomway β-Nicotinamide Mononucleotide (NMN) Production, Value, Price and Gross Margin (2020-2025)

7.9.4 Kingdomway Main Business and Markets Served

7.9.5 Kingdomway Recent Developments/Updates

7.10 ABA Chemical

7.10.1 ABA Chemical β-Nicotinamide Mononucleotide (NMN) Company Information

7.10.2 ABA Chemical β-Nicotinamide Mononucleotide (NMN) Product Portfolio

7.10.3 ABA Chemical β-Nicotinamide Mononucleotide (NMN) Production, Value, Price and Gross Margin (2020-2025)

7.10.4 ABA Chemical Main Business and Markets Served

7.10.5 ABA Chemical Recent Developments/Updates

8 Industry Chain and Sales Channels Analysis

8.1 β-Nicotinamide Mononucleotide (NMN) Industry Chain Analysis

8.2 β-Nicotinamide Mononucleotide (NMN) Raw Material Supply Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.3 β-Nicotinamide Mononucleotide (NMN) Production Mode & Process Analysis

8.4 β-Nicotinamide Mononucleotide (NMN) Sales and Marketing

8.4.1 β-Nicotinamide Mononucleotide (NMN) Sales Channels

8.4.2 β-Nicotinamide Mononucleotide (NMN) Distributors

8.5 β-Nicotinamide Mononucleotide (NMN) Customer Analysis

9 β-Nicotinamide Mononucleotide (NMN) Market Dynamics

9.1 β-Nicotinamide Mononucleotide (NMN) Industry Trends

9.2 β-Nicotinamide Mononucleotide (NMN) Market Drivers

9.3 β-Nicotinamide Mononucleotide (NMN) Market Challenges

9.4 β-Nicotinamide Mononucleotide (NMN) Market Restraints

10 Research Findings and Conclusion

11 Methodology and Data Source

11.1 Methodology/Research Approach

11.1.1 Research Programs/Design

11.1.2 Market Size Estimation

11.1.3 Market Breakdown and Data Triangulation

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Author List

11.4 Disclaimer

FEATURED COMPANIES

GeneHarbor

Herbalmax

Genex Formulas

Maac10 Formulas

EffePharm

Bontac

CELFULL

Kingdomway

Mirailab Bioscience

ABA Chemical

List of Tables

Table 1. Global β-Nicotinamide Mononucleotide (NMN) Market Value by Type, (US$ Million) & (2024 VS 2031)

Table 2. Global β-Nicotinamide Mononucleotide (NMN) Market Value by Application, (US$ Million) & (2024 VS 2031)

Table 3. Global β-Nicotinamide Mononucleotide (NMN) Production Capacity (Tons) by Manufacturers in 2024

Table 4. Global β-Nicotinamide Mononucleotide (NMN) Production by Manufacturers (2020-2025) & (Tons)

Table 5. Global β-Nicotinamide Mononucleotide (NMN) Production Market Share by Manufacturers (2020-2025)

Table 6. Global β-Nicotinamide Mononucleotide (NMN) Production Value by Manufacturers (2020-2025) & (US$ Million)

Table 7. Global β-Nicotinamide Mononucleotide (NMN) Production Value Share by Manufacturers (2020-2025)

Table 8. Global Key Players of β-Nicotinamide Mononucleotide (NMN), Industry Ranking, 2023 VS 2024

Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in β-Nicotinamide Mononucleotide (NMN) as of 2024)

Table 10. Global Market β-Nicotinamide Mononucleotide (NMN) Average Price by Manufacturers (US$/Kg) & (2020-2025)

Table 11. Global Key Manufacturers of β-Nicotinamide Mononucleotide (NMN), Manufacturing Base Distribution and Headquarters

Table 12. Global Key Manufacturers of β-Nicotinamide Mononucleotide (NMN), Product Offered and Application

Table 13. Global Key Manufacturers of β-Nicotinamide Mononucleotide (NMN), Date of Enter into This Industry

Table 14. Global β-Nicotinamide Mononucleotide (NMN) Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global β-Nicotinamide Mononucleotide (NMN) Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global β-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) by Region (2020-2025)

Table 18. Global β-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Region (2020-2025)

Table 19. Global β-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) Forecast by Region (2026-2031)

Table 20. Global β-Nicotinamide Mononucleotide (NMN) Production Value Market Share Forecast by Region (2026-2031)

Table 21. Global β-Nicotinamide Mononucleotide (NMN) Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)

Table 22. Global β-Nicotinamide Mononucleotide (NMN) Production (Tons) by Region (2020-2025)

Table 23. Global β-Nicotinamide Mononucleotide (NMN) Production Market Share by Region (2020-2025)

Table 24. Global β-Nicotinamide Mononucleotide (NMN) Production (Tons) Forecast by Region (2026-2031)

Table 25. Global β-Nicotinamide Mononucleotide (NMN) Production Market Share Forecast by Region (2026-2031)

Table 26. Global β-Nicotinamide Mononucleotide (NMN) Market Average Price (US$/Kg) by Region (2020-2025)

Table 27. Global β-Nicotinamide Mononucleotide (NMN) Market Average Price (US$/Kg) by Region (2026-2031)

Table 28. Global β-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)

Table 29. Global β-Nicotinamide Mononucleotide (NMN) Consumption by Region (2020-2025) & (Tons)

Table 30. Global β-Nicotinamide Mononucleotide (NMN) Consumption Market Share by Region (2020-2025)

Table 31. Global β-Nicotinamide Mononucleotide (NMN) Forecasted Consumption by Region (2026-2031) & (Tons)

Table 32. Global β-Nicotinamide Mononucleotide (NMN) Forecasted Consumption Market Share by Region (2026-2031)

Table 33. North America β-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)

Table 34. North America β-Nicotinamide Mononucleotide (NMN) Consumption by Country (2020-2025) & (Tons)

Table 35. North America β-Nicotinamide Mononucleotide (NMN) Consumption by Country (2026-2031) & (Tons)

Table 36. Europe β-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)

Table 37. Europe β-Nicotinamide Mononucleotide (NMN) Consumption by Country (2020-2025) & (Tons)

Table 38. Europe β-Nicotinamide Mononucleotide (NMN) Consumption by Country (2026-2031) & (Tons)

Table 39. Asia Pacific β-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)

Table 40. Asia Pacific β-Nicotinamide Mononucleotide (NMN) Consumption by Region (2020-2025) & (Tons)

Table 41. Asia Pacific β-Nicotinamide Mononucleotide (NMN) Consumption by Region (2026-2031) & (Tons)

Table 42. Latin America, Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)

Table 43. Latin America, Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Consumption by Country (2020-2025) & (Tons)

Table 44. Latin America, Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Consumption by Country (2026-2031) & (Tons)

Table 45. Global β-Nicotinamide Mononucleotide (NMN) Production (Tons) by Type (2020-2025)

Table 46. Global β-Nicotinamide Mononucleotide (NMN) Production (Tons) by Type (2026-2031)

Table 47. Global β-Nicotinamide Mononucleotide (NMN) Production Market Share by Type (2020-2025)

Table 48. Global β-Nicotinamide Mononucleotide (NMN) Production Market Share by Type (2026-2031)

Table 49. Global β-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) by Type (2020-2025)

Table 50. Global β-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) by Type (2026-2031)

Table 51. Global β-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Type (2020-2025)

Table 52. Global β-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Type (2026-2031)

Table 53. Global β-Nicotinamide Mononucleotide (NMN) Price (US$/Kg) by Type (2020-2025)

Table 54. Global β-Nicotinamide Mononucleotide (NMN) Price (US$/Kg) by Type (2026-2031)

Table 55. Global β-Nicotinamide Mononucleotide (NMN) Production (Tons) by Application (2020-2025)

Table 56. Global β-Nicotinamide Mononucleotide (NMN) Production (Tons) by Application (2026-2031)

Table 57. Global β-Nicotinamide Mononucleotide (NMN) Production Market Share by Application (2020-2025)

Table 58. Global β-Nicotinamide Mononucleotide (NMN) Production Market Share by Application (2026-2031)

Table 59. Global β-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) by Application (2020-2025)

Table 60. Global β-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) by Application (2026-2031)

Table 61. Global β-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Application (2020-2025)

Table 62. Global β-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Application (2026-2031)

Table 63. Global β-Nicotinamide Mononucleotide (NMN) Price (US$/Kg) by Application (2020-2025)

Table 64. Global β-Nicotinamide Mononucleotide (NMN) Price (US$/Kg) by Application (2026-2031)

Table 65. GeneHarbor β-Nicotinamide Mononucleotide (NMN) Company Information

Table 66. GeneHarbor β-Nicotinamide Mononucleotide (NMN) Specification and Application

Table 67. GeneHarbor β-Nicotinamide Mononucleotide (NMN) Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 68. GeneHarbor Main Business and Markets Served

Table 69. GeneHarbor Recent Developments/Updates

Table 70. Herbalmax β-Nicotinamide Mononucleotide (NMN) Company Information

Table 71. Herbalmax β-Nicotinamide Mononucleotide (NMN) Specification and Application

Table 72. Herbalmax β-Nicotinamide Mononucleotide (NMN) Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 73. Herbalmax Main Business and Markets Served

Table 74. Herbalmax Recent Developments/Updates

Table 75. Genex Formulas β-Nicotinamide Mononucleotide (NMN) Company Information

Table 76. Genex Formulas β-Nicotinamide Mononucleotide (NMN) Specification and Application

Table 77. Genex Formulas β-Nicotinamide Mononucleotide (NMN) Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 78. Genex Formulas Main Business and Markets Served

Table 79. Genex Formulas Recent Developments/Updates

Table 80. Mirailab Bioscience β-Nicotinamide Mononucleotide (NMN) Company Information

Table 81. Mirailab Bioscience β-Nicotinamide Mononucleotide (NMN) Specification and Application

Table 82. Mirailab Bioscience β-Nicotinamide Mononucleotide (NMN) Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 83. Mirailab Bioscience Main Business and Markets Served

Table 84. Mirailab Bioscience Recent Developments/Updates

Table 85. Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Company Information

Table 86. Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Specification and Application

Table 87. Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 88. Maac10 Formulas Main Business and Markets Served

Table 89. Maac10 Formulas Recent Developments/Updates

Table 90. EffePharm β-Nicotinamide Mononucleotide (NMN) Company Information

Table 91. EffePharm β-Nicotinamide Mononucleotide (NMN) Specification and Application

Table 92. EffePharm β-Nicotinamide Mononucleotide (NMN) Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 93. EffePharm Main Business and Markets Served

Table 94. EffePharm Recent Developments/Updates

Table 95. Bontac β-Nicotinamide Mononucleotide (NMN) Company Information

Table 96. Bontac β-Nicotinamide Mononucleotide (NMN) Specification and Application

Table 97. Bontac β-Nicotinamide Mononucleotide (NMN) Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 98. Bontac Main Business and Markets Served

Table 99. Bontac Recent Developments/Updates

Table 100. CELFULL β-Nicotinamide Mononucleotide (NMN) Company Information

Table 101. CELFULL β-Nicotinamide Mononucleotide (NMN) Specification and Application

Table 102. CELFULL β-Nicotinamide Mononucleotide (NMN) Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 103. CELFULL Main Business and Markets Served

Table 104. CELFULL Recent Developments/Updates

Table 105. Kingdomway β-Nicotinamide Mononucleotide (NMN) Company Information

Table 106. Kingdomway β-Nicotinamide Mononucleotide (NMN) Specification and Application

Table 107. Kingdomway β-Nicotinamide Mononucleotide (NMN) Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 108. Kingdomway Main Business and Markets Served

Table 109. Kingdomway Recent Developments/Updates

Table 110. ABA Chemical β-Nicotinamide Mononucleotide (NMN) Company Information

Table 111. ABA Chemical β-Nicotinamide Mononucleotide (NMN) Specification and Application

Table 112. ABA Chemical β-Nicotinamide Mononucleotide (NMN) Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 113. ABA Chemical Main Business and Markets Served

Table 114. ABA Chemical Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. β-Nicotinamide Mononucleotide (NMN) Distributors List

Table 118. β-Nicotinamide Mononucleotide (NMN) Customers List

Table 119. β-Nicotinamide Mononucleotide (NMN) Market Trends

Table 120. β-Nicotinamide Mononucleotide (NMN) Market Drivers

Table 121. β-Nicotinamide Mononucleotide (NMN) Market Challenges

Table 122. β-Nicotinamide Mononucleotide (NMN) Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. Authors List of This Report

List of Figures

Figure 1. Product Picture of β-Nicotinamide Mononucleotide (NMN)

Figure 2. Global β-Nicotinamide Mononucleotide (NMN) Market Value by Type, (US$ Million) & (2020-2031)

Figure 3. Global β-Nicotinamide Mononucleotide (NMN) Market Share by Type: 2024 VS 2031

Figure 4. Content ≥98% Product Picture

Figure 5. Content ＜98% Product Picture

Figure 6. Global β-Nicotinamide Mononucleotide (NMN) Market Value by Application, (US$ Million) & (2020-2031)

Figure 7. Global β-Nicotinamide Mononucleotide (NMN) Market Share by Application: 2024 VS 2031

Figure 8. Health Care Products

Figure 9. Cosmetics

Figure 10. Others

Figure 11. Global β-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global β-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) & (2020-2031)

Figure 13. Global β-Nicotinamide Mononucleotide (NMN) Production Capacity (Tons) & (2020-2031)

Figure 14. Global β-Nicotinamide Mononucleotide (NMN) Production (Tons) & (2020-2031)

Figure 15. Global β-Nicotinamide Mononucleotide (NMN) Average Price (US$/Kg) & (2020-2031)

Figure 16. β-Nicotinamide Mononucleotide (NMN) Report Years Considered

Figure 17. β-Nicotinamide Mononucleotide (NMN) Production Share by Manufacturers in 2024

Figure 18. Global β-Nicotinamide Mononucleotide (NMN) Production Value Share by Manufacturers (2024)

Figure 19. β-Nicotinamide Mononucleotide (NMN) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. The Global 5 and 10 Largest Players: Market Share by β-Nicotinamide Mononucleotide (NMN) Revenue in 2024

Figure 21. Global β-Nicotinamide Mononucleotide (NMN) Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 22. Global β-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Region: 2020 VS 2024 VS 2031

Figure 23. Global β-Nicotinamide Mononucleotide (NMN) Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)

Figure 24. Global β-Nicotinamide Mononucleotide (NMN) Production Market Share by Region: 2020 VS 2024 VS 2031

Figure 25. North America β-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) Growth Rate (2020-2031)

Figure 26. China β-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) Growth Rate (2020-2031)

Figure 27. Japan β-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) Growth Rate (2020-2031)

Figure 28. Global β-Nicotinamide Mononucleotide (NMN) Consumption by Region: 2020 VS 2024 VS 2031 (Tons)

Figure 29. Global β-Nicotinamide Mononucleotide (NMN) Consumption Market Share by Region: 2020 VS 2024 VS 2031

Figure 30. North America β-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2020-2031) & (Tons)

Figure 31. North America β-Nicotinamide Mononucleotide (NMN) Consumption Market Share by Country (2020-2031)

Figure 32. U.S. β-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2020-2031) & (Tons)

Figure 33. Canada β-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2020-2031) & (Tons)

Figure 34. Europe β-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2020-2031) & (Tons)

Figure 35. Europe β-Nicotinamide Mononucleotide (NMN) Consumption Market Share by Country (2020-2031)

Figure 36. Germany β-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2020-2031) & (Tons)

Figure 37. France β-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2020-2031) & (Tons)

Figure 38. U.K. β-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2020-2031) & (Tons)

Figure 39. Italy β-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2020-2031) & (Tons)

Figure 40. Russia β-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2020-2031) & (Tons)

Figure 41. Asia Pacific β-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2020-2031) & (Tons)

Figure 42. Asia Pacific β-Nicotinamide Mononucleotide (NMN) Consumption Market Share by Region (2020-2031)

Figure 43. China β-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2020-2031) & (Tons)

Figure 44. Japan β-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2020-2031) & (Tons)

Figure 45. South Korea β-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2020-2031) & (Tons)

Figure 46. China Taiwan β-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2020-2031) & (Tons)

Figure 47. Southeast Asia β-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2020-2031) & (Tons)

Figure 48. India β-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2020-2031) & (Tons)

Figure 49. Latin America, Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2020-2031) & (Tons)

Figure 50. Latin America, Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Consumption Market Share by Country (2020-2031)

Figure 51. Mexico β-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2020-2031) & (Tons)

Figure 52. Brazil β-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2020-2031) & (Tons)

Figure 53. Turkey β-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2020-2031) & (Tons)

Figure 54. GCC Countries β-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2020-2031) & (Tons)

Figure 55. Global Production Market Share of β-Nicotinamide Mononucleotide (NMN) by Type (2020-2031)

Figure 56. Global Production Value Market Share of β-Nicotinamide Mononucleotide (NMN) by Type (2020-2031)

Figure 57. Global β-Nicotinamide Mononucleotide (NMN) Price (US$/Kg) by Type (2020-2031)

Figure 58. Global Production Market Share of β-Nicotinamide Mononucleotide (NMN) by Application (2020-2031)

Figure 59. Global Production Value Market Share of β-Nicotinamide Mononucleotide (NMN) by Application (2020-2031)

Figure 60. Global β-Nicotinamide Mononucleotide (NMN) Price (US$/Kg) by Application (2020-2031)

Figure 61. β-Nicotinamide Mononucleotide (NMN) Value Chain

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions